Search

everythinglearnresearchcommunity

for

Search:↓

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Testosterone replacement therapy can prevent men from fathering children and should not be used by those wanting to stay fertile.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

New physical methods like electrical currents, ultrasound, and microneedles show promise for improving drug delivery through the skin.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Laser Doppler velocimetry is a valuable noninvasive tool for skin blood flow research in dermatology.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Androgens can both increase body hair and cause scalp hair loss.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

PCOS is complex, affects many, and requires informed management and lifestyle changes.

Age-related immune changes worsen Parkinson's disease, suggesting new treatment strategies.

The metoprolol-spironolactone combination improves heart function in patients with coronary heart disease and heart failure.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Personalized treatment and teamwork among doctors can reduce chemotherapy side effects and improve patient outcomes.

PCOS is a hormonal disorder causing symptoms like irregular periods and acne, and increases the risk of diabetes and heart disease.